EP2325171
Quinoline derivatives for treating retinal diseases
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.5.2006EP published:
9.10.2013EP application number:
11155225.3
EPO information:
European Patent Register
Max expiry date:
25.5.2026
Title:
Quinoline derivatives for treating retinal diseases
Timeline
Today
26.5.2006EP application
9.10.2013EP Publication
Owner
Name:
Aldexa Therapeutics, Inc.Address:
15 New England Executive Park, 01803, Burlington, MA, US
Inventor
Name:
Jordan, Thomas AAddress:
Lexington, MA, US
Name:
Dowling, John E.Address:
BOSTON, MA, US
Name:
Chabala, John C.Address:
New Jersey, NJ, US
Priority
Number:
685460 PDate:
26.5.2005Country:
US
Number:
723577 PDate:
4.10.2005Country:
US
Classification
Categories:
C07D 215/38, A61K 31/435